Gilead Sciences, Inc. SEC filings GILD
Gilead Sciences, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Apr 4, 2018. Its latest annual report, Form ARS, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| N-PX | Filing | Aug 26, 2026 | Jun 30, 2026 |
| SC TO-T/A | Filing | Apr 28, 2026 | — |
| SC TO-T/A | Filing | Apr 17, 2026 | — |
| SC TO-T/A | Filing | Apr 1, 2026 | — |
| SC TO-T | Filing | Mar 6, 2026 | — |
| SC TO-C | Filing | Feb 23, 2026 | — |
| SC TO-C | Filing | Feb 23, 2026 | — |
| N-PX | Filing | Aug 29, 2025 | Jun 30, 2025 |
| PX14A6G | Filing | Apr 7, 2025 | — |
| SC TO-T/A | Filing | Mar 22, 2024 | — |
| SC TO-T/A | Filing | Mar 20, 2024 | — |
| SC TO-T/A | Filing | Mar 15, 2024 | — |
| CORRESP | Letter to the SEC | Mar 11, 2024 | — |
| SC TO-T/A | Filing | Mar 11, 2024 | — |
| SC TO-T/A | Filing | Feb 28, 2024 | — |
| SC TO-T | Filing | Feb 23, 2024 | — |
| SC TO-C | Form sc to-c | Feb 14, 2024 | — |
| SC TO-C | Form sc to-c | Feb 12, 2024 | — |
| SC TO-C | Form sc to-c | Feb 12, 2024 | — |
| UPLOAD | Letter from the SEC | May 5, 2023 | — |
| CORRESP | Letter to the SEC | Apr 25, 2023 | — |
| PX14A6G | Filing | Apr 6, 2023 | — |
| DEFR14A | Filing | Apr 5, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 29, 2023 | — |
| PX14A6G | Filing | Mar 29, 2023 | — |
| PX14A6G | Filing | Apr 11, 2022 | — |
| PX14A6G | Filing | Apr 7, 2022 | — |
| PX14A6G | Gilead sciences, inc | Apr 5, 2022 | — |
| CT ORDER | Filing | Feb 2, 2022 | — |
| PX14A6G | Filing | Apr 19, 2021 | — |
| SC TO-T/A | Filing | Oct 23, 2020 | — |
| SC TO-T/A | Filing | Oct 14, 2020 | — |
| SC TO-T/A | Filing | Oct 13, 2020 | — |
| SC TO-T/A | Filing | Oct 2, 2020 | — |
| CORRESP | Letter to the SEC | Oct 2, 2020 | — |
| SC TO-T/A | Filing | Sep 25, 2020 | — |
| SC TO-T | Filing | Sep 24, 2020 | — |
| SC TO-C | Form sc to-c | Sep 24, 2020 | — |
| SC TO-C | Form sc to-c | Sep 17, 2020 | — |
| SC TO-C | Form sc to-c | Sep 16, 2020 | — |
| SC TO-C | Form sc to-c | Sep 15, 2020 | — |
| SC TO-C | Form sc to-c | Sep 14, 2020 | — |
| SC TO-C | Form sc to-c | Sep 14, 2020 | — |
| CT ORDER | Filing | Apr 14, 2020 | — |
| CT ORDER | Filing | Apr 14, 2020 | — |
| CT ORDER | Filing | Apr 14, 2020 | — |
| SC TO-T/A | Filing | Apr 7, 2020 | — |
| SC TO-T/A | Filing | Mar 30, 2020 | — |
| PX14A6G | Filing | Mar 26, 2020 | — |
| SC TO-T/A | Filing | Mar 23, 2020 | — |
| SC TO-T/A | Filing | Mar 17, 2020 | — |
| SC TO-T/A | Filing | Mar 12, 2020 | — |
| SC TO-T | Filing | Mar 10, 2020 | — |
| SC TO-C | Filing | Mar 3, 2020 | — |
| SC TO-C | Filing | Mar 2, 2020 | — |
| SC TO-C | Filing | Mar 2, 2020 | — |
| CT ORDER | Filing | Jan 28, 2020 | — |
| CT ORDER | Filing | Jul 12, 2019 | — |
| CT ORDER | Filing | Jul 12, 2019 | — |
| CT ORDER | Filing | Jun 7, 2019 | — |
| CT ORDER | Filing | Feb 21, 2019 | — |
| CT ORDER | Filing | Nov 13, 2018 | — |
| CT ORDER | Filing | Sep 27, 2018 | — |
| CT ORDER | Filing | Sep 14, 2018 | — |
| CT ORDER | Filing | Aug 16, 2018 | — |
| CT ORDER | Filing | May 18, 2018 | — |
Showing 66 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- GILD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Foster City, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 882095
- Former names
- GILEAD SCIENCES INC (until Feb 17, 2022)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
- Neurocrine Biosciences Inc NBIX
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.